Fort Myers, FLNCT06906341Now EnrollingIRB Ready

Ovarian Cancer Clinical Trial in Fort Myers, FL

Access cutting-edge ovarian cancer treatment through this phase 2 clinical trial at a research site in Fort Myers. Study-provided care at no cost to qualified participants.

Sponsored by Corcept Therapeutics

Quick Self-Assessment

See if you qualify for this Fort Myers location

Preparing your pre-screening questions…

Expert Care in Fort Myers

Access ovarian cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ovarian cancer treatment provided free

Apply for This Fort Myers Location

Check if you qualify for this ovarian cancer clinical trial in Fort Myers, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fort Myers

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fort Myers site if eligible
  4. 4Begin participation

About This Ovarian Cancer Study in Fort Myers

This is a Phase 2, single-arm, open-label study to evaluate efficacy and safety of intermittent dosing of relacorilant in combination with nab-paclitaxel and bevacizumab in patients with ovarian cancer.

Sponsor: Corcept Therapeutics

Who Can Participate

Inclusion Criteria

Arms A and B
Histologic diagnosis of epithelial ovarian, primary peritoneal, or fallopian-tube carcinoma
Arm A Only: Platinum-resistant disease
Arm B Only: Platinum-sensitive disease who had progression while receiving treatment with a poly(ADP-ribose) polymerase (PARP) inhibitor
Life expectancy of ≥3 months
Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
Able to swallow and retain oral medication
1 to 3 lines of prior systemic anticancer therapy
Adequate organ function
Negative pregnancy test for patients of childbearing potential Arm C
Stage III or IV, recurrent, or metastatic endometrial cancer
Life expectancy of ≥3 months
ECOG performance status of 0 or 1
Able to swallow and retain oral medication
Prior treatment with a platinum agent and an approved anti-Programmed Cell Death Ligand 1 (PD\[L\]1) antibody
1 to 2 lines of prior systemic anticancer therapy for endometrial cancer
Must consent to provide an available formalin-fixed paraffin-embedded (FFPE) tumor tissue block or recently cut sections
Adequate organ function
Negative pregnancy test for patients of childbearing potential

Exclusion Criteria

Arm A and B
Arm A Only: Has progressed while receiving weekly paclitaxel or nab-paclitaxel
Prior enrollment in a clinical trial of relacorilant
Prior anticancer therapy related toxicities not resolved to grade ≤1
Any surgery within 4 weeks prior to enrollment
Wide-field radiation to more than 25% of marrow-bearing areas
Medical conditions requiring chronic or frequent treatment with corticosteroids
Concurrent treatment with mifepristone or other glucocorticoid receptor modulators
Peripheral neuropathy from any cause \>Grade 1
Hypertension: ≥150 mm Hg systolic or ≥100 mm Hg diastolic
Uncontrolled condition(s) which, may confound the results of the trial or interfere with the patient's safety or participation
Bowel obstruction ≤12 weeks prior to study entry
Ascites or pleural effusions requiring therapeutic paracentesis
Untreated or symptomatic central nervous system metastases
History of other malignancy within 3 years prior to enrollment
Has received a live vaccine within 30 days prior to the study start date Arm C
Has progressed while receiving weekly paclitaxel or nab-paclitaxel
Prior enrollment in a clinical trial of relacorilant
Prior anticancer therapy related toxicities not resolved to grade ≤1
Any surgery within 4 weeks prior to enrollment
Wide-field radiation to more than 25% of marrow-bearing areas
Medical conditions requiring chronic or frequent treatment with corticosteroids
Concurrent treatment with mifepristone or other glucocorticoid receptor modulators
Peripheral neuropathy from any cause \>Grade 1
Uncontrolled condition(s) which, may confound the results of the trial or interfere with the patient's safety or participation
Bowel obstruction ≤12 weeks prior to study entry
Ascites or pleural effusions requiring therapeutic paracentesis
History of other malignancy within 3 years prior to enrollment
Has received a live vaccine within 30 days prior to the study start date
Patients with central nervous system metastases are not eligible, unless they have completed local therapy and have discontinued the use of corticosteroids for this indication for at least 4 weeks before starting treatment in this study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fort Myers?

Yes, this clinical trial (NCT06906341) has an active research site in Fort Myers, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ovarian Cancer Treatment Options in Fort Myers, FL

If you're searching for ovarian cancer treatment options in Fort Myers, FL, this clinical trial (NCT06906341) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fort Myers research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ovarian cancer clinical trials near you to find additional studies recruiting in your area.

More Ovarian Cancer Trials in Fort Myers, FL

See all ovarian cancer clinical trials recruiting in Fort Myers — not just this study.

Browse Ovarian Cancer Trials in Fort Myers →

Browse More Trials by Condition

Ovarian Cancer TrialsAll Conditions →

Ready to Join in Fort Myers?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fort Myers, FL